BUENA, N.J., March 1, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, March 7, 2017 to discuss the 4th quarter and year end 2016 results.
The Company invites you to listen to the call by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian participants should call 1-855-669-9657. Participants should ask to be joined into the Teligent, Inc. call.
This call is being webcast by MultiVu (a PR Newswire Company) and can be accessed in the Investor Relations Section of Teligent Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact: | Jenniffer Collins |
Teligent, Inc. | |
(856) 697-4379 | |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-hold-conference-call-for-4th-quarter-and-year-end-2016-results-300415631.html
SOURCE Teligent, Inc.
